Question 1

What is the catalog number for AHCYL2 Knockout AGS Polyclonal Cells?

Accepted Answer

The catalog number for AHCYL2 Knockout AGS Polyclonal Cells is ARG26499.

Question 2

What sizes are available for AHCYL2 Knockout AGS Polyclonal Cells?

Accepted Answer

AHCYL2 Knockout AGS Polyclonal Cells is available in the following size(s): 1 Million.

Question 3

Is AHCYL2 Knockout AGS Polyclonal Cells in stock?

Accepted Answer

AHCYL2 Knockout AGS Polyclonal Cells is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Are there any special shipping requirements for AHCYL2 Knockout AGS Polyclonal Cells?

Accepted Answer

AHCYL2 Knockout AGS Polyclonal Cells is requires dry ice shipping.

Question 5

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 6

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Question 7

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

AHCYL2 Knockout AGS Polyclonal Cells

Product Specifications

Type

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

gamma Tubulin (TUBG1) (434-449) Mouse Monoclonal Antibody [Clone ID: TU-32]

UBE2D2 Mouse Monoclonal Antibody [Clone ID: OTI1D11]

Tissue FFPE Sections, Endometrium

CD73 (Immuno-Oncology Target) (NT5E/2503), CF640R conjugate, 0.1mg/mL

Human IGFL2 activation kit by CRISPRa

MOSPD1 Human Gene Knockout Kit (CRISPR)